S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Intellinetics Stock Forecast, Price & News

-0.19 (-2.31%)
(As of 11/26/2021 12:46 PM ET)
Today's Range
50-Day Range
52-Week Range
16,177 shs
Average Volume
3,299 shs
Market Capitalization
$22.73 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive INLX News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellinetics and its competitors with MarketBeat's FREE daily newsletter.

Intellinetics logo

About Intellinetics

Intellinetics, Inc. engages in the provision of document services and software solutions to private and public sectors. It operates through the following segments: Document Management and Document Conversion. The Document Management segment allows customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video and emails. The Document Conversion provides assistance to clients as a part of overall document strategy to convert documents from one medium to another, predominantly paper to digital, including migration to software solutions, as well as long-term storage and retrieval services. The company was founded by A. Michael Chretien, Matthew L. Chretien, and Thomas D. Moss on October 3, 1997 and is headquartered in Columbus, OH.


See More Headlines

Industry, Sector and Symbol

Prepackaged software
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$8.25 million
Cash Flow
$0.22 per share
Book Value
$0.93 per share


Net Income
$-2.20 million
Pretax Margin




Free Float
Market Cap
$22.73 million
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End


Overall MarketRank

1.25 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Intellinetics (OTCMKTS:INLX) Frequently Asked Questions

How has Intellinetics' stock been impacted by COVID-19?

Intellinetics' stock was trading at $0.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, INLX shares have increased by 9,962.5% and is now trading at $8.05.
View which stocks have been most impacted by COVID-19

Are investors shorting Intellinetics?

Intellinetics saw a drop in short interest in the month of October. As of October 29th, there was short interest totaling 100 shares, a drop of 90.0% from the October 14th total of 1,000 shares. Based on an average daily volume of 3,900 shares, the days-to-cover ratio is currently 0.0 days.
View Intellinetics' Short Interest

How were Intellinetics' earnings last quarter?

Intellinetics, Inc. (OTCMKTS:INLX) released its quarterly earnings data on Monday, November, 15th. The company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.09. Intellinetics had a negative net margin of 0.84% and a positive trailing twelve-month return on equity of 33.63%.
View Intellinetics' earnings history

Who are Intellinetics' key executives?

Intellinetics' management team includes the following people:
  • James F. DeSocio, President, Chief Executive Officer & Director
  • Mike Beck, Vice President-Operations
  • Joe Spain, Chief Financial Officer & Treasurer
  • Matt Chretien, Secretary, Director, CTO & Chief Strategy Officer
  • Thomas D. Moss, Vice President-Research & Development

What other stocks do shareholders of Intellinetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intellinetics investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Kopin (KOPN), Onconova Therapeutics (ONTX), OPKO Health (OPK), Precipio (PRPO), Selecta Biosciences (SELB), Sierra Oncology (SRRA) and T2 Biosystems (TTOO).

What is Intellinetics' stock symbol?

Intellinetics trades on the OTCMKTS under the ticker symbol "INLX."

How do I buy shares of Intellinetics?

Shares of INLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Intellinetics' stock price today?

One share of INLX stock can currently be purchased for approximately $8.05.

How much money does Intellinetics make?

Intellinetics has a market capitalization of $22.73 million and generates $8.25 million in revenue each year. The company earns $-2.20 million in net income (profit) each year or ($0.08) on an earnings per share basis.

How many employees does Intellinetics have?

Intellinetics employs 94 workers across the globe.

What is Intellinetics' official website?

The official website for Intellinetics is www.intellinetics.com.

Where are Intellinetics' headquarters?

Intellinetics is headquartered at 2190 DIVIDEND DRIVE, COLUMBUS OH, 43228.

How can I contact Intellinetics?

Intellinetics' mailing address is 2190 DIVIDEND DRIVE, COLUMBUS OH, 43228. The company can be reached via phone at (614) 921-8170 or via email at [email protected].

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]arketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.